✦ LIBER ✦

Antibody-targeted chemotherapy of B-cell lymphoma using calicheamicin conjugated to murine or humanized antibody against CD22

✍ Scribed by John F. DiJoseph; Andrew Popplewell; Simon Tickle; Heather Ladyman; Alastair Lawson; Arthur Kunz; Kiran Khandke; Douglas C. Armellino; Erwin R. Boghaert; Philip R. Hamann; Karen Zinkewich-Peotti; Sue Stephens; Neil Weir; Nitin K. Damle

Book ID: 105966801
Publisher: Springer-Verlag
Year: 2004
Tongue: English
Weight: 463 KB
Volume: 54
Category: Article
ISSN: 0340-7004
DOI: 10.1007/s00262-004-0572-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CD20-specific antibody-targeted chemothe

CD20-specific antibody-targeted chemotherapy of non-Hodgkin’s B-cell lymphoma using calicheamicin-conjugated rituximab

✍ John F. DiJoseph; Maureen M. Dougher; Douglas C. Armellino; Lyka Kalyandrug; Art 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 341 KB

Mouse monoclonal antibodies against the

Mouse monoclonal antibodies against the idiotype of human B cell non-Hodgkin lymphomas: production, characterization and use to monitor the progress of disease

✍ Elaine M. Rankin; Annemarie Hekman 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 863 KB

Peptide-antibody conjugates for tumour t

Peptide-antibody conjugates for tumour therapy: A MHC-class-II-restricted tetanus toxin peptide coupled to an anti-IG light chain antibody can induce cytotoxic lysis of a human B-cell lymphoma by specific CD4 T cells

✍ Zhiwei Yu; Frank Healy; Danila Valmori; Patricia Escobar; Giampietro Corradin; J 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 729 KB

Anti-idiotype antibody therapy of B-cell lymphomas, despite numerous promising experimental and clinical studies, has so far met with limited success. Tailor-made monoclonal antiidiotype antibodies have been injected into a large series of lymphoma patients, with a few impressive complete tumour rem